Tenofovir vaginal film as a potential MPT product against HIV-1 and HSV-2 acquisition: formulation development and preclinical assessment in non-human primates.

Patel, Sravan Kumar; Agashe, Hrushikesh; Patton, Dorothy L; Sweeney, Yvonne; Beamer, May A; Hendrix, Craig W; Hillier, Sharon L; Rohan, Lisa C

Patel, Sravan Kumar; Agashe, Hrushikesh; Patton, Dorothy L; Sweeney, Yvonne; Beamer, May A; Hendrix, Craig W; Hillier, Sharon L; Rohan, Lisa C.

Afiliación

Patel SK; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States.
Agashe H; Magee-Womens Research Institute, Pittsburgh, PA, United States.
Patton DL; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States.
Sweeney Y; Magee-Womens Research Institute, Pittsburgh, PA, United States.
Beamer MA; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.
Hendrix CW; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.
Hillier SL; Magee-Womens Research Institute, Pittsburgh, PA, United States.
Rohan LC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Front Reprod Health ; 5: 1217835, 2023.

Article en En | MEDLINE | ID: mdl-37638127

Palabras clave

HIV prevention; genital herpes; multipurpose technology; tenofovir; vaginal film; women health

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Front Reprod Health Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google